US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 4, 2020 (6 years ago)

Day & Night Pack Ear Itch MD Anti-Itch Spray

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations.

What was recalled

Day & Night Pack Ear Itch MD Anti-Itch Spray (pramoxine HCL 1%), 0.5 FL OZ (15 mL) bottles/Ear Itch MD Nighttime Intensive Soothing Spray (pramoxine HCL 1%), 0.5 FL OZ (15 mL) bottles, Eosera, Inc. 5000 South Freeway Fort Worth, TX 76115, NDC 72429-0071-5

Recalling firm
Eosera, Inc.
NDC code
72429-0071-5
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1501-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pramoxine recalls

See all
Class II · Moderate risk Terminated

Proctofoam HC

Reason cGMP deficiencies

Mylan Pharmaceuticals Inc NDC 0037-6822-10 D-0452-2022
Class II · Moderate risk Terminated

Proctofoam HC

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 0037-6822-10 D-0529-2021
Class II · Moderate risk Terminated

Ear Itch MD Anti-Itch Spray

Reason cGMP Deviations.

Eosera, Inc. NDC 72429-0071-5 D-1500-2020
Class III · Low risk Terminated

Novacort Gel Sample Packets

Reason Subpotent Drug: Out of specification result for pramoxine hydrochloride

Novum Pharma, LLC NDC 69646-704-38 D-0433-2017